Journal
Genome Medicine
Uniquely positioned at the interface between omics and medicine, Genome Medicine is BMC's flagship journal focusing on the application of genetics, genomics and multi-omics to...
Genome Medicine is calling for submissions to our Collection on the tumor immune contexture in cancer progression and treatment. This Collection seeks to capture recent insights in characterizing and mapping the tumor immune contexture, dissecting response to immunotherapy, exploring anti-tumor immune responses, and uncovering parameters associated with patient outcomes, highlighting the clinical applications of these advances.
Submit your manuscript to this collection through the participating journal.
-
Noel De Miranda: Leiden University Medical Centre, the Netherlands
Noel de Miranda is the Principal Investigator of the Cancer Immunogenomics group and Associate Professor at the department of Pathology of the Leiden University Medical Center, The Netherlands. Dr. de Miranda’s group combines the use of high-end genomic, transcriptomic, and proteomic (single cell and spatial) technologies for the study of cancer genetics and immunology. The main aim of the group is to support the development of novel therapies to enrich the immunotherapy toolbox for the treatment of advanced cancers.